| scholarly article | Q13442814 |
| P2093 | author name string | Hepeng Jia | |
| Keiko Kandachi | |||
| Sue Pearson | |||
| P433 | issue | 1 | |
| P921 | main subject | People's Republic of China | Q148 |
| gene therapy | Q213901 | ||
| P304 | page(s) | 3-4 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Nature Biotechnology | Q1893837 |
| P1476 | title | China approves first gene therapy | |
| P478 | volume | 22 |
| Q52692695 | A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy. |
| Q26849375 | A short perspective on gene therapy: Clinical experience on gene therapy of gliomablastoma multiforme |
| Q39308911 | An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance |
| Q92731114 | Anti-Colorectal Cancer Effects of Probiotic-Derived p8 Protein |
| Q46303317 | Antisense oligonucleotides targeting translation inhibitory elements in 5' UTRs can selectively increase protein levels |
| Q47344432 | Antisense oligonucleotides: the next frontier for treatment of neurological disorders |
| Q40447916 | Avian adenovirus vector CELO-TK displays anticancer activity in human cancer cells and suppresses established murine melanoma tumors. |
| Q81105337 | Can China bring its own pipeline to the market? |
| Q35946185 | Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides. |
| Q36226789 | Cancer-specific gene therapy. |
| Q45872061 | Challenges and opportunities in bioanalytical support for gene therapy medicinal product development |
| Q37427230 | Charge-reversal lipids, peptide-based lipids, and nucleoside-based lipids for gene delivery. |
| Q82498045 | China offers alternative gateway for experimental drugs |
| Q34734228 | Chinese health biotech and the billion-patient market |
| Q43978844 | Clinical trials and SCID row: the ethics of phase 1 trials in the developing world |
| Q33820501 | Dendrimers: synthesis, applications, and properties |
| Q90681476 | Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders |
| Q26782083 | Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs |
| Q38848060 | Evolving lessons on nanomaterial-coated viral vectors for local and systemic gene therapy |
| Q37166374 | Functional lipids and lipoplexes for improved gene delivery. |
| Q64093774 | Gene Therapy Leaves a Vicious Cycle |
| Q39027588 | Gene delivery nanoparticles to modulate angiogenesis |
| Q87006288 | Gene therapy |
| Q39711498 | Gene therapy in HIV-infected cells to decrease viral impact by using an alternative delivery method |
| Q36922247 | Gene therapy of gynaecological diseases |
| Q36594242 | Gene therapy works in animal models of rheumatoid arthritis...so what! |
| Q45883377 | Gene therapy: cursed or inching towards credibility? |
| Q59794799 | Genomic Interventions in Medicine |
| Q54333544 | Guanidiniocarbonyl pyrrole (GCP) conjugated PAMAM-G2, a highly efficient vector for gene delivery: the importance of DNA condensation. |
| Q90352523 | Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis |
| Q37850449 | In vivo nucleic acid delivery with PEI and its derivatives: current status and perspectives |
| Q35285768 | Induction of interferon pathways mediates in vivo resistance to oncolytic adenovirus |
| Q81256910 | Is more really less in China's new drug approvals? |
| Q34893725 | Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm |
| Q26741086 | Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks |
| Q53623512 | Mutational analysis of the p53 core domain L1 loop. |
| Q42562347 | Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies. |
| Q38848223 | Oncolytic Immunotherapy for Treatment of Cancer |
| Q36998666 | Opportunities and barriers to establishing a cell therapy programme in South Africa. |
| Q37425316 | Orphan drug development in China - Turning challenges into opportunities |
| Q92730835 | Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy |
| Q38156233 | Poly(amidoamine) dendrimer complexes as a platform for gene delivery. |
| Q48253463 | Progress in biopharmaceutical development. |
| Q55239952 | Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect. |
| Q38226307 | Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications |
| Q34648372 | Recombinant adenoviral vectors can induce expression of p73 via the E4-orf6/7 protein |
| Q34750424 | Regulation of the target protein (transgene) expression in the adenovirus vector using agonists of toll-like receptors. |
| Q90315744 | Relaxed natural selection contributes to global obesity increase more in males than in females due to more environmental modifications in female body mass |
| Q36710840 | Restoration of wild-type p53 function in human cancer: relevance for tumor therapy. |
| Q37818222 | Sitimagene ceradenovec: a gene-based drug for the treatment of operable high-grade glioma |
| Q39390082 | Specific Increase of Protein Levels by Enhancing Translation Using Antisense Oligonucleotides Targeting Upstream Open Frames |
| Q37449030 | Specifically targeted gene therapy for small-cell lung cancer. |
| Q58566968 | Targeted Intracellular Delivery of Antibodies: The State of the Art |
| Q33655329 | Targeting p53 for Novel Anticancer Therapy |
| Q37338454 | The effect and role of carbon atoms in poly(β-amino ester)s for DNA binding and gene delivery. |
| Q38189250 | The evolution of adenoviral vectors through genetic and chemical surface modifications |
| Q37721932 | The hunt for gene dopers. |
| Q38660339 | The state of gene therapy research in Africa, its significance and implications for the future. |
| Q38042630 | Therapeutic strategies for head and neck cancer based on p53 status |
| Q46286420 | Translation efficiency of mRNAs is increased by antisense oligonucleotides targeting upstream open reading frames |
| Q47111189 | Updates from the TP53 universe |
| Q35753524 | Use of suicide genes for cancer gene therapy: study of the different approaches. |
| Q35915700 | What is a cure and how do we get there? |
| Q36370715 | Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma |
Search more.